Please assess the completion status of the following clinical trial:

Trial Title: Mission is Remission®: How Can a Disease Self-management Website Change Care?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Pediatric IBD patients (approximately 100 patients randomly assigned to the Mission is Remission® group or the wait-list control group) and one of their parents/primary caregivers;~2. Patient is between 12-18 years of age, inclusive;~3. Meets screening criteria for low self-efficacy;~4. Signed informed consent from parent and assent from patient.~Exclusion Criteria:~1. Not English speaking;~2. Children with cognitive impairment.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Mission is Remission® Group (Type: EXPERIMENTAL): Participants in this group will be given access to the Mission is Remission® web-based teaching and support site. They will also be emailed a link to complete online questionnaires at set time points throughout the study.
- Control Group (Type: NO_INTERVENTION): Participants in this group will continue to receive standard care without access to the Mission is Remission® website. They will also be emailed a link to complete online questionnaires. At the end of the 6 month study period, participants in this group will be given access to the study website.

Based on this trial design, predict the completion outcome and termination type (if applicable).